Pregnancy: There are no adequate data from the use of vildagliptin in pregnant women. Studies in animals have shown reproductive toxicity at high doses. The potential risk for humans is unknown.
Due to lack of human data, Vildagliptin should not be used during pregnancy.
Breast-feeding: It is unknown whether vildagliptin is excreted in human milk. Animal studies have shown excretion of vildagliptin in milk. Vildagliptin should not be used during breast-feeding.
Fertility: No studies on the effect on human fertility have been conducted for Vildagliptin.
Other Services
Country
Account